An open label study on the efficacy and safety of donepezil hydrochloride (Aricept) in vascular dementia.

Trial Profile

An open label study on the efficacy and safety of donepezil hydrochloride (Aricept) in vascular dementia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 May 2012

At a glance

  • Drugs Donepezil (Primary)
  • Indications Vascular dementia
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Apr 2009 Additional trial investigator Jacqueline Dominguez added as reported by ClinicalTrials.gov.
    • 01 Apr 2009 Additional trial centre Eisai Inc. added as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top